3054692-62-2
3054692-62-2
Chemical Structure
ECI830
Synonym(s): CDK2-IN-37
- CAS No.: 3054692-62-2
- Formula:C19H24N6O3
- Molecular Weight:384.43
InChIKey: YIXKYJBZOFQJFD-VXGBXAGGSA-N
SMILES: O=C1N([C@@H]2CCC[C@@H](O)C2)C3=NC(NC4=CNN=C4OCC)=NC=C3C15CC5
Biological Activity: ECI830 (CDK2-IN-37) is an orally active, ATP-competitive and highly selective CDK2 inhibitor. ECI830 shows high selectivity over other CDK family members. ECI830 can be used for the study of HR+/HER2- breast cancer and CCNE1-amplified tumors (such as ovarian cancer and lung cancer)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ECI830 | 98.01% | ECI830 (CDK2-IN-37) is an orally active, ATP-competitive and highly selective CDK2 inhibitor. ECI830 shows high selectivity over other CDK family members. ECI830 can be used for the study of HR+/HER2- breast cancer and CCNE1-amplified tumors (such as ovarian cancer and lung cancer). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
